ArticleFrontiers in digital health2026
MAPSeg: self-supervised colorectal polyp segmentation via memory-augmented framework and synthetic polyp simulation.
Article in Frontiers in digital health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Colorectal cancer originates in most cases from polyps that progressively become malignant over time and colonoscopy offers a highly studied early diagnostic strategy to ensure a timely treatment plan. Automatic image segmentation of polyps, using intelligent supervised approaches, achieved good performance, but the need of their large annotated datasets limits the clinical applicability. Methods: This study presents MAPSeg (Memory-Augmented Polyp Segmentation), a fully self-supervised and annotation-free framework for colorectal polyp segmentation, trained exclusively on images of healthy mucosa within an anomaly detection paradigm. The key novelty of MAPSeg mainly lies in SIMPO (Simulation of Polyps), a synthetic augmentation strategy that generates realistic polyp shapes and textures in a colon-specific context, combined with a memory-augmented encoder that models structural priors of normal tissue. Results: Extensive experiments demonstrate that MAPSeg outperforms the strongest unsupervised methods by approximately 23% in Intersection over Union and 12% in DICE score on the Hyper-Kvasir dataset and consistently maintains this performance margin across multiple out-of-distribution benchmarks, indicating strong generalization capability. Discussion: The results highlight MAPSeg supported by SIMPO as a viable solution for unsupervised colorectal polyp segmentation, significantly reducing the dependency on manual annotations while maintaining high segmentation accuracy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.